Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

Julia Antoinette Messina

Associate Professor of Medicine
Medicine, Infectious Diseases
Hanes House Room 150, Box DUMC 102359, Durham, NC 27710

Overview


I am a Transplant Infectious Diseases Physician who specializes in the care of immunocompromised patients including solid organ and bone marrow transplant recipients and patients with HIV. My research interests are in infections and clinical outcomes in patients with hematologic malignancies.

Current Appointments & Affiliations


Associate Professor of Medicine · 2025 - Present Medicine, Infectious Diseases, Medicine
Member of the Duke Cancer Institute · 2025 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published November 8, 2014
Students Innovate on Ebola

View All News

Recent Publications


Association of appropriate empiric antimicrobial therapy with acute kidney injury in gram-negative sepsis.

Journal Article J Intensive Care Soc · October 9, 2025 BACKGROUND: Despite advances in sepsis management, the relationship between appropriate empiric antibiotic therapy and acute kidney injury (AKI) in sepsis remains unclear. This study aimed to examine the association of appropriate empiric antimicrobial the ... Full text Link to item Cite

The Pain is in the Brain with the Sugar-Coated Killer.

Journal Article J Infect Dis · September 24, 2025 Cryptococcus neoformans and C. gattii represent encapsulated yeasts which have become increasingly common central nervous system (CNS) pathogens during the enlarging age of the immunocompromised host. CNS disease represents a major interaction between the ... Full text Link to item Cite

Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.

Journal Article Open Forum Infect Dis · September 2025 Infections are increasingly recognized as a complication of chimeric antigen receptor T-cell (CAR-T) therapy however the incidence of infections after non-CD19 targeted CAR-T is not yet known. We report, for the first time, infectious complications after C ... Full text Link to item Cite
View All Publications

Recent Grants


sHLH Natural History

ResearchPrincipal Investigator · Awarded by Electra Therapeutics · 2025 - 2026

View All Grants

Education, Training & Certifications


Duke University, School of Medicine · 2018 M.H.S.
Virginia Commonwealth University, School of Medicine · 2010 M.D.